Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3213 Target Snapshot

85/88 kDa calcium-independent phospholipase A2 · SINGLE PROTEIN · Homo sapiens

183Compounds
47Assays
0Approved Drugs
35.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt O60733. Use UniProt O60733 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O60733 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 85/88 kDa calcium-independent phospholipase A2 as ChEMBL target CHEMBL3213, mapped to UniProt O60733. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
85/88 kDa calcium-independent phospholipase A2
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3213
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
O60733
85/88 kDa calcium-independent phospholipase A2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 85/88 kDa calcium-independent phospholipase A2 is the right protein anchor across sources, using UniProt O60733 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label85/88 kDa calcium-independent phospholipase A2
UniProt AccessionO60733
Component TypeProtein
Sequence Length806 aa

85/88 kDa calcium-independent phospholipase A2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 85/88 kDa calcium-independent phospholipase A2, mapped to UniProt O60733. Sequence length is 806 aa.

Mapped IDO60733
Review name85/88 kDa calcium-independent phospholipase A2
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase II
Assay Mix

Activity Type Distribution

IC5035.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4476476 9.0 IC50 1.0 Preclinical
CHEMBL6223 7.52 IC50 30.0 Preclinical
CHEMBL89506 7.34 IC50 46.0 Preclinical
CHEMBL148674 7.25 IC50 56.0 Clinical
CHEMBL4438490 7.05 IC50 90.0 Preclinical
CHEMBL269758 7.02 IC50 95.0 Preclinical
CHEMBL6206 6.85 IC50 140.0 Preclinical
CHEMBL6228 6.72 IC50 190.0 Preclinical
CHEMBL4439384 5.46 IC50 3500.0 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
7
5.5
3
6.0
6
6.5
14
7.0
1
7.5
0
8.0
0
8.5
1
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

47
Total Assays
9
Tested Compounds
1
Assay Types
Binding — 47 assays, 9 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 41 5 6.7
cell-based format 5 0
tissue-based format 1 4 7.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine